Sensus Healthcare (SRTS) Competitors $8.94 +0.57 (+6.81%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SRTS vs. SSKN, SIBN, TMCI, CATX, TCMD, ZIMV, RCEL, SMLR, NNOX, and CVRXShould you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include STRATA Skin Sciences (SSKN), SI-BONE (SIBN), Treace Medical Concepts (TMCI), Perspective Therapeutics (CATX), Tactile Systems Technology (TCMD), ZimVie (ZIMV), AVITA Medical (RCEL), Semler Scientific (SMLR), Nano-X Imaging (NNOX), and CVRx (CVRX). These companies are all part of the "medical equipment" industry. Sensus Healthcare vs. STRATA Skin Sciences SI-BONE Treace Medical Concepts Perspective Therapeutics Tactile Systems Technology ZimVie AVITA Medical Semler Scientific Nano-X Imaging CVRx STRATA Skin Sciences (NASDAQ:SSKN) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment, community ranking and earnings. Does the MarketBeat Community prefer SSKN or SRTS? STRATA Skin Sciences received 41 more outperform votes than Sensus Healthcare when rated by MarketBeat users. However, 68.42% of users gave Sensus Healthcare an outperform vote while only 63.90% of users gave STRATA Skin Sciences an outperform vote. CompanyUnderperformOutperformSTRATA Skin SciencesOutperform Votes22363.90% Underperform Votes12636.10% Sensus HealthcareOutperform Votes18268.42% Underperform Votes8431.58% Do insiders and institutionals hold more shares of SSKN or SRTS? 32.4% of STRATA Skin Sciences shares are held by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are held by institutional investors. 39.0% of STRATA Skin Sciences shares are held by insiders. Comparatively, 9.4% of Sensus Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more risk and volatility, SSKN or SRTS? STRATA Skin Sciences has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500. Is SSKN or SRTS more profitable? Sensus Healthcare has a net margin of 22.54% compared to STRATA Skin Sciences' net margin of -28.72%. Sensus Healthcare's return on equity of 17.99% beat STRATA Skin Sciences' return on equity.Company Net Margins Return on Equity Return on Assets STRATA Skin Sciences-28.72% -69.33% -17.55% Sensus Healthcare 22.54%17.99%16.26% Does the media prefer SSKN or SRTS? In the previous week, Sensus Healthcare had 24 more articles in the media than STRATA Skin Sciences. MarketBeat recorded 33 mentions for Sensus Healthcare and 9 mentions for STRATA Skin Sciences. Sensus Healthcare's average media sentiment score of 0.85 beat STRATA Skin Sciences' score of -0.12 indicating that Sensus Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STRATA Skin Sciences 1 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sensus Healthcare 10 Very Positive mention(s) 3 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer SSKN or SRTS? Sensus Healthcare has a consensus price target of $12.50, suggesting a potential upside of 39.82%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than STRATA Skin Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score STRATA Skin Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has higher earnings and valuation, SSKN or SRTS? Sensus Healthcare has lower revenue, but higher earnings than STRATA Skin Sciences. STRATA Skin Sciences is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSTRATA Skin Sciences$33.36M0.39-$10.83M-$2.66-1.16Sensus Healthcare$24.41M6.00$490K$0.5715.68 SummarySensus Healthcare beats STRATA Skin Sciences on 14 of the 19 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get Sensus Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRTS vs. The Competition Export to ExcelMetricSensus HealthcareSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$137.09M$4.47B$5.07B$8.90BDividend YieldN/A36.79%4.99%4.07%P/E Ratio15.6813.2787.8613.46Price / Sales6.0044.831,228.8287.66Price / Cash144.8652.2739.5136.27Price / Book2.715.776.946.30Net Income$490,000.00$13.76M$119.12M$225.93M7 Day Performance22.63%-1.10%-1.84%-1.32%1 Month Performance32.84%0.56%-3.65%0.60%1 Year Performance327.75%50.90%31.64%26.23% Sensus Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRTSSensus Healthcare4.0682 of 5 stars$8.94+6.8%$12.50+39.8%+331.9%$137.09M$24.41M15.6840Analyst ForecastAnalyst RevisionHigh Trading VolumeSSKNSTRATA Skin Sciences0.5787 of 5 stars$3.09+2.0%N/A-40.7%$12.64M$33.36M0.00120SIBNSI-BONE4.3736 of 5 stars$12.15-1.4%$23.00+89.3%-32.6%$516.68M$138.89M0.00350Analyst ForecastInsider TradeAnalyst RevisionTMCITreace Medical Concepts1.0224 of 5 stars$7.98+2.8%$7.40-7.3%-7.1%$483.42M$187.12M0.00250CATXPerspective Therapeutics2.7597 of 5 stars$6.16-9.1%$21.57+250.2%N/A$458.24M$1.43M0.00116Analyst RevisionTCMDTactile Systems Technology3.7846 of 5 stars$15.56-1.3%$23.00+47.8%+23.1%$378.43M$274.42M23.94980ZIMVZimVie2.5824 of 5 stars$13.49+2.4%$18.33+35.9%+49.2%$363.48M$457.43M0.002,600RCELAVITA Medical1.4051 of 5 stars$13.05+0.7%$16.50+26.4%+4.1%$339.78M$50.14M0.00130SMLRSemler Scientific1.0709 of 5 stars$59.27+27.9%N/A+60.6%$336.72M$68.18M28.9192Gap UpHigh Trading VolumeNNOXNano-X Imaging1.7461 of 5 stars$5.89+3.5%$14.00+137.7%-10.5%$328.76M$9.90M0.00190CVRXCVRx2.0918 of 5 stars$13.52+0.7%$15.83+17.1%-25.8%$325.62M$39.29M0.00200 Related Companies and Tools Related Companies SSKN Alternatives SIBN Alternatives TMCI Alternatives CATX Alternatives TCMD Alternatives ZIMV Alternatives RCEL Alternatives SMLR Alternatives NNOX Alternatives CVRX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SRTS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensus Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensus Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
